Calendar

pharmadog

Week of Apr 13, 2026

Apr 14, 2026approval90d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalMILNACIPRAN HYDROCHLORIDE

Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

full page →MILNACIPRAN HYDROCHLORIDE →fda approvals ↗

Apr 14, 2026approval90d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalMILNACIPRAN HYDROCHLORIDE

Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

full page →MILNACIPRAN HYDROCHLORIDE →fda approvals ↗

Apr 14, 2026approval90d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalMILNACIPRAN HYDROCHLORIDE

Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

full page →MILNACIPRAN HYDROCHLORIDE →fda approvals ↗

Apr 14, 2026approval90d agoDANZITEN (NILOTINIB TARTRATE) — FDA approvalDANZITEN

Sponsor: AZURITY. Form: TABLET. Route: ORAL

full page →DANZITEN →fda approvals ↗

Apr 14, 2026approval90d agoSONAZINE (CHLORPROMAZINE HYDROCHLORIDE) — FDA approvalSaptalis Pharmaceuticals LLC

Sponsor: SAPTALIS PHARMS. Form: CONCENTRATE. Route: ORAL

full page →fda approvals ↗

Apr 14, 2026approval90d agoRYTELO (IMETELSTAT SODIUM) — FDA approvalimetelstat sodium

Sponsor: GERON. Form: POWDER. Route: INTRAVENOUS

full page →imetelstat sodium →fda approvals ↗

Apr 14, 2026approval90d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 14, 2026approval90d agoBOSENTAN — FDA approvalBOSENTAN

Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

full page →BOSENTAN →fda approvals ↗

Apr 14, 2026approval90d agoBOSENTAN — FDA approvalBOSENTAN

Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

full page →BOSENTAN →fda approvals ↗

Apr 14, 2026approval90d agoCANAGLIFLOZIN — FDA approvalCANAGLIFLOZIN

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →CANAGLIFLOZIN →fda approvals ↗

Apr 14, 2026approval90d agoLACTULOSE — FDA approvalCUMBERLAND PHARMACEUTICALS INC

Sponsor: CUMBERLAND PHARMS. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Apr 14, 2026approval90d agoABREVA (DOCOSANOL) — FDA approvalPL Developments Copiague LLC

Sponsor: HALEON US HOLDINGS. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

Apr 14, 2026approval90d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 14, 2026approval90d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 14, 2026grant90d agoUNIVERSITY OF KANSAS MEDICAL CENTER — 25th Annual Midwest DNA Repair SymposiumUniversity of Kansas Medical Center

ES grant. $15,000. PI: Ryan P Barnes

full page →nih reporter ↗

Apr 14, 2026grant90d agoLOUISIANA STATE UNIV A&M COL BATON ROUGE — Stent-based sensor system for continuous monitoring of mechanical biomarkers ...

EB grant. $143,201. PI: Robert Herbert

full page →nih reporter ↗

Apr 14, 2026grant90d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Ultra-long-acting in-situ forming implant (ISFI) as a subcutaneous injection ...

AI grant. $1,106,984. PI: Soumya Rahima Benhabbour

full page →nih reporter ↗

Apr 14, 2026grant90d agoUNIVERSITY OF CALIFORNIA AT DAVIS — Pollutant-adsorbed nanoplastics (PANs): the influence of physicochemical prop...

ES grant. $765,348. PI: Randy Carney

full page →nih reporter ↗

Apr 14, 2026grant90d agoWADSWORTH CENTER — Mapping the determinants of bedaquiline resistance in Mycobacterium tuberculosis

AI grant. $403,756. PI: Joseph Thomas Wade

full page →nih reporter ↗

Apr 14, 2026grant90d agoUNIVERSITY OF CENTRAL OKLAHOMA — PRAISE (Pressure Relief Assessment Information System): A Paradigm-shifting M...

EB grant. $381,392. PI: Jicheng Fu

full page →nih reporter ↗

Apr 14, 2026grant90d agoLEHIGH UNIVERSITY — Creating protease-responsive hydrogels to generate cell-specific niches withi...

EB grant. $616,375. PI: Eugene Thomas Pashuck

full page →nih reporter ↗

Apr 14, 2026grant90d agoUNIVERSITY OF VIRGINIA — Preserving lung integrity and harnessing inflammation to treat vesicant-induc...University of Virginia

ES grant. $1,460,280. PI: Chuanxi Cai

full page →nih reporter ↗

Apr 14, 2026grant90d agoUNIVERSITY OF PENNSYLVANIA — Impact of Mechanical Circulatory Support and Microbiome Change on Outcomes in...University of Pennsylvania

AI grant. $196,020. PI: Alyssa K Mezochow

full page →nih reporter ↗

Apr 14, 2026grant90d agoAMERICAN SOCIETY OF PREVENTIVE ONCOLOGY, INC. — 2026 Annual Conference Grant: American Society of Preventive Oncology

CA grant. $40,000. PI: Michael E. Scheurer

full page →nih reporter ↗

Apr 15, 2026approval89d agoGLYCEROL PHENYLBUTYRATE — FDA approvalLupin Ltd

Sponsor: TEVA PHARMS INC. Form: LIQUID. Route: ORAL

full page →fda approvals ↗

Apr 15, 2026approval89d agoDIACOMIT (STIRIPENTOL) — FDA approvalstiripentol

Sponsor: BIOCODEX SA. Form: CAPSULE. Route: ORAL

full page →stiripentol →fda approvals ↗

Apr 15, 2026approval89d agoSTELARA (USTEKINUMAB) — FDA approvalJOHNSON & JOHNSON

Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 15, 2026approval89d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

Apr 15, 2026approval89d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 15, 2026approval89d agoMETHOTREXATE SODIUM — FDA approvalMaxtrex

Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION

full page →Maxtrex →fda approvals ↗

Apr 15, 2026approval89d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 15, 2026approval89d agoWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvaleplontersen sodium

Sponsor: ASTRAZENECA AB. Form: SOLUTION. Route: SUBCUTANEOUS

full page →eplontersen sodium →fda approvals ↗

Apr 15, 2026approval89d agoGLYCEROL PHENYLBUTYRATE — FDA approvalGLYCEROL PHENYLBUTYRATE

Sponsor: AUROBINDO PHARMA. Form: LIQUID

full page →GLYCEROL PHENYLBUTYRATE →fda approvals ↗

Apr 15, 2026approval89d agoRAMELTEON — FDA approvalRAMELTEON

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →RAMELTEON →fda approvals ↗

Apr 15, 2026approval89d agoALENDRONATE SODIUM — FDA approvalOrganon & Co.

Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 15, 2026approval89d agoSODIUM BICARBONATE — FDA approvalSODIUM BICARBONATE

Sponsor: ASPIRO. Form: SOLUTION. Route: INTRAVENOUS

full page →SODIUM BICARBONATE →fda approvals ↗

Apr 15, 2026approval89d agoGLYCEROL PHENYLBUTYRATE — FDA approvalGLYCEROL PHENYLBUTYRATE

Sponsor: MSN. Form: LIQUID. Route: ORAL

full page →GLYCEROL PHENYLBUTYRATE →fda approvals ↗

Apr 15, 2026approval89d agoDEXTROMETHORPHAN POLISTIREX — FDA approvalDEXTROMETHORPHAN POLISTIREX

Sponsor: AUROBINDO PHARMA LTD. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL

full page →DEXTROMETHORPHAN POLISTIREX →fda approvals ↗

Apr 15, 2026approval89d agoDIACOMIT (STIRIPENTOL) — FDA approvalstiripentol

Sponsor: BIOCODEX SA. Form: FOR SUSPENSION. Route: ORAL

full page →stiripentol →fda approvals ↗

Apr 15, 2026approval89d agoZOLEDRONIC ACID — FDA approvalNOVARTIS AG

Sponsor: MYLAN LABS LTD. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Apr 15, 2026approval89d agoSTELARA (USTEKINUMAB) — FDA approvalustekinumab

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →ustekinumab →fda approvals ↗

Apr 15, 2026approval89d agoATROPINE SULFATE — FDA approvalEdenbridge Pharmaceuticals LLC

Sponsor: EDENBRIDGE PHARMS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Apr 15, 2026approval89d agoBUSPIRONE HYDROCHLORIDE — FDA approvalOxford Pharmaceuticals LLC

Sponsor: OXFORD PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 15, 2026approval89d agoCOLESTIPOL HYDROCHLORIDE — FDA approvalCarnegie Pharmaceuticals LLC

Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 15, 2026approval89d agoCOLESTIPOL HYDROCHLORIDE — FDA approvalCarnegie Pharmaceuticals LLC

Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 15, 2026approval89d agoCOLESTIPOL HYDROCHLORIDE — FDA approvalCarnegie Pharmaceuticals LLC

Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 15, 2026approval89d agoONTRUZANT (TRASTUZUMAB-DTTB) — FDA approvalONTRUZANT

Sponsor: SAMSUNG BIOEPIS CO LTD. Form: POWDER. Route: IV (INFUSION)

full page →ONTRUZANT →fda approvals ↗

Apr 15, 2026approval89d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION

full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗

Apr 15, 2026approval89d agoBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalIGC Pharma, Inc.

Sponsor: DR REDDYS LABS SA. Form: FILM. Route: BUCCAL, SUBLINGUAL

full page →fda approvals ↗

Apr 15, 2026approval89d agoBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalIGC Pharma, Inc.

Sponsor: DR REDDYS LABS SA. Form: FILM. Route: BUCCAL, SUBLINGUAL

full page →fda approvals ↗

← prev

page 1 of 10

Week of Apr 13, 2026